Slide thumbnailPKPD Backgroundsign2 drug devbanner button white background

The Go-To Resource for PK/PD Based Drug Development

Let Our Pharmacokineticists Guide You

Slide thumbnail


new hands parallaxbanner button white background

Look at Drug Development Through a New Lens

Start with Understanding How Your Drug Interacts with the Body

Slide thumbnail2. building2. building background

The Most Experienced

PK/PD Group

Our team of 25+ Pharmacokineticists

makes complex PK/PD principles usable

for common sense drug development.

Slide thumbnailThe Foundation of Drug Development

PK/PD – The Foundation of Intelligent Drug Development

More Than Just PK/PD Analysis & Reporting

Slide thumbnail4-therapeutic

Therapeutic Area


Nuventra's team has

drug development

expertise across

many therapeutic areas.

Slide thumbnaildarwin backgroundFDA APPROVED

DARWIN – The Next Generation of Population PK Modeling

More Robust, More Objective, Faster, Reproducible & Cost Effective

Slide thumbnailetk

Introducing eTK

High Quality, Automated, Toxicokinetic Analysis & Reporting

Nuventra Pharma Sciences

Nuventra was founded in 2008 and is based on the philosophy of providing excellence in clinical pharmacology, pharmacokinetics, pharmacodynamics, and pharmacometrics (population PK). As such, the range of our experience in this area of drug development is broad and extensive, which translates into better advice and services for our clients. Nuventra helps pharmaceutical and biotechnology companies understand how drugs interact with the body and how the body interacts with drugs.


A common sense approach based on scientific principles to provide excellence in pharmacokinetics.
Learn More


Using 'Concentration-QT’ PK/PD Analysis to Eliminate the need for a Thorough QT Study. Learn More

'Darwin' Genetic Algorithm for PopPK

Automated PopPK model selection via computer algorithm...named 'Darwin for NONMEM'...saves time and money.
Learn More

Virtual PK Group

Senior level consultants provide expert services to companies lacking pharmacokinetic and clinical pharmacology expertise in-house.
Learn More

Nuventra is the pharmaceutical industry’s go-to resource for PK/PD analysis and provides pharmaceutical companies and CROs rare access to a hands-on team of industry-leading consultants experienced in complex studies and analyses across multiple therapeutic areas. We embrace the notion that simplicity and clarity lead to good decisions by taking complex pharmacokinetic, pharmacodynamic, and pharmacometric (popPK) principles and making them understandable and usable for common sense drug development. Nuventra’s flexible business structure enables our expert consultants to integrate within our clients’ R&D group and help them maximize the potential of their clinical pharmacology/Phase 1 study and PK/PD analysis to pave the way toward marketing approval.

Nearly 1/4th of the information in the product label or package insert is based on PK/PD (dosing, drug interactions, use in different patients, absorption, distribution, metabolism, and excretion, etc.) – Let us guide your PK/PD development strategy.

Clinical Pharmacology Plan

Hear about our "Clinical Pharmacology Plan" for an overall drug development program.

Conducting a Typical PK Analysis

Learn about our process for conducting pharmacokinetic analyses.

Nuventra Delivers Clinical Pharmacology & PK Consulting Services

Hear how Nuventra is changing the paradigm for delivering expertise in pharmacokinetics.

What Makes Nuventra Different

Dr. Geoffrey Banks, Nuventra's CEO discusses what makes our company different.


The Nuventra Advantage

  • Our Consultants

    Our consultants don't just give you PK and PD data, we are adept at presenting complex pharmacokinetic data in a manner that is usable for rational drug development.
  • Our Experience

    Our expert senior consultants have 15 to 30 years of experience in clinical pharmacology, TK, DMPK, PK, PD, PK/PD and pharmacometrics
  • Our Focus

    With our focus in drug development, Nuventra's consultants see a tremendous diversity of compounds, development programs, and complex analyses. These experiences allow Nuventra to be the best partner for companies developing small molecule therapeutics and biologics
  • Your Partner

    We integrate into our client's R&D group and become an extension of their operation. This allows us to be a true partner in drug development beyond just a simple client-vendor relationship.
  • Strategic Advice

    Rather than evaluate an individual study or analysis in a silo, Nuventra's consultants take a horizontal approach to providing strategic advice across an entire development program. We help interpret and apply PK data from clinical and nonclinical studies to next steps in a development program.
  • Phase 1 Studies

    Nuventra uses scientific principals to design, conduct, analyze and report clinical pharmacology Phase 1 studies.